David J. Cohen, MD, MPH, MSc

What is the Annual Volume Requirement for a PCI Operator?

Santiago Garcia , MD;

Lucas Burke , MD;

Leo Gozdecki , DO;

Anthony A. Bavry , MD, MPH;

Demetrios Doukas , DO;

Kendrick A. Shunk , MD, PhD;

Cara Joyce , PhD;

Frances Weaver , PhD;

Verghese Mathew , MD;

Our objective was to compare patient-level risk assessment at eight Veterans Affairs hospitals in patients undergoing transcatheter aortic valve replacement with patients included in the Society for Thoracic Surgeons/American College of...

Our objective was to compare...

07/31/2020

Journal of Invasive Cardiology

Clinical Editor's Corner

12/05/2017

Gregg W. Stone , MD, FACC, FSCAI;

Lloyd W. Klein , MD;

Duane S. Pinto , MD, MPH;

Zoltan G. Turi , MD;

Ted Feldman , MD, FSCAI, FACC, FESC;

Ajay J. Kirtane , MD, SM;

Frederic S. Resnic , MD, MSc;

Jeffrey J. Popma , MD, FACC, FSCAI;

George W. Vetrovec , MD;

Charles E. Chambers , MD;

Steven R. Bailey , MD;

Richard G. Bach , MD;

Current Clinical Characteristics and Economic Impact of Subacute Stent Thrombosis

Gregory J. Dehmer , MD;

Larry S. Dean , MD, FACC, FAHA, FSCAI;

Kirk N. Garratt , MD, MSc;

Many of the editor’s pages come from issues raised by practicing interventionalists. Recently, a query came to our colleague, Dr. Zoltan Turi, from a chief of cardiology.

Many of the editor’s pages come...

12/05/2017

Cath Lab Digest

08/01/2008

Michael J. Rinaldi , MD, FACC, FSCAI;

Matthew R. Reynolds , MD, MSc;

Duane S. Pinto , MD, MPH;

Conversations in Cardiology: Who Should Scrub the Groin? Is the Cath Lab Just Like the OR?

Stent thrombosis represents an infrequent but potentially grave complication of percutaneous coronary intervention (PCI). With current antithrombotic regimens, stent thrombosis occurs after fewer than 1% of stent-based interventions,1,2 but...

Stent thrombosis represents an...

08/01/2008

Journal of Invasive Cardiology

02/26/2015

Lloyd W. Klein , MD;

Bonnie H. Weiner , MD, MBA, FSCAI, FACC;

Charles E. Chambers , MD;

Peter Ver Lee , MD;

Practice and Outcomes of Percutaneous Coronary Intervention in the Community Before Drug-Eluting Stents: A Report from the HCA D

Jeffrey Marshall ;

Gurpreet S. Sandhu , MD, PhD;

Malcolm R. Bell , MD;

William J. French ;

Jeff Marshall: I have a question about who should scrub the groin or wrist before a cardiac cath or peripheral procedure.

Jeff Marshall: I have a question...

02/26/2015

Cath Lab Digest

08/01/2008

Salvatore L. Battaglia , MD, BS;

Lynn G. Tarkington , RN;

Edmund R. Becker , PhD;

Steven D. Culler , PhD;

Michael J. Mack , MD, FACC;

Aaron D. Kugelmass , MD;

Should Diagnostic-Only Operators Continue? Retool or Retire Redux

Frank Houser , MD;

April W. Simon , RN, MSN;

Rapid advancements in percutaneous coronary interventional (PCI) techniques have changed the manner in which we treat coronary artery disease.1 Clinical trials have demonstrated the efficacy of coronary stents in preventing abrupt vessel...

Rapid advancements in...

08/01/2008

Journal of Invasive Cardiology

Clinical Editor's Corner

12/05/2021

Samuel M. Butman , MD;

Jeffrey Marshall ;

Gurpreet S. Sandhu , MD, PhD;

Carl L. Tommaso , MD;

J. Dawn Abbott , MD;

The Influence of Diabetes Mellitus on the Practice and Outcomes of Percutaneous Coronary Intervention in the Community: A Report

Bonnie H. Weiner , MD, MBA, FSCAI, FACC;

An interventionist in the southeastern United States asked me this question at TCT. The issue is quite an old one, but still relevant and perhaps more so now with the proliferation of fractional flow reserve (FFR), instantaneous wave-free...

An interventionist in the...

12/05/2021

Cath Lab Digest

08/01/2008

Aaron D. Kugelmass , MD;

Conversations in Cardiology: Do Contrast Media Reactions Still Happen? Will Your Lab Know What to Do?

Frank Houser , MD;

April W. Simon , RN, MSN;

Salvatore L. Battaglia , MD, BS;

Lynn G. Tarkington , RN;

Michael J. Mack , MD, FACC;

Edmund R. Becker , PhD;

Steven D. Culler , PhD;

Diabetic patients with coronary artery disease (CAD) have poorer long-term prognosis with more revascularization procedures than non-diabetic patients regardless of the initial treatment strategy.1,2 The role of percutaneous versus surgical...

Diabetic patients with coronary...

08/01/2008

Journal of Invasive Cardiology

Clinical Editor's Corner

10/06/2021

George W. Vetrovec , MD;

John S. Marshall ;

Arnold H. Seto , MD, MPA, CCDS, FACC, FSCAI;

Thomas Bashore ;

John W. Hirshfeld Jr.;

Samuel M. Butman , MD;

Prashant Kaul , MD, FACC, FSCAI;

Ajay J. Kirtane , MD, SM;

David E. Kandzari , MD;

Bailout Use of Platelet Glycoprotein IIb/IIIa Inhibition During Coronary Stent Implantation: Observations from the ESPRIT Trial

Adnan K. Chhatriwalla , MD;

A middle-aged man underwent a routine cath for coronary artery disease that showed non-obstructive mild coronary narrowings.

A middle-aged man underwent a...

10/06/2021

Cath Lab Digest

08/01/2008

James E. Tcheng , MD;

Michael M. Kitt , MD;

Coronary Thrombosis in the Time of COVID-19 – A Puzzling Entity (With Video Discussion)

Robert J. Chisholm , MD, FRCPC;

Henry K. Lui , MD;

Robert L. Feldman , MD;

Robert Green , MD;

Anne S. Hellkamp , PhD;

Warren J. Cantor , MD;

J. Conor O'Shea , MD;

Mina Madan , MD, MPH;

Potent inhibition of platelet aggregation during percutaneous coronary intervention (PCI) using intravenous antagonists of the platelet glycoprotein (GP) IIb/IIIa receptor results in a significant and sustained reduction in the occurrence of...

Potent inhibition of platelet...

08/01/2008

Journal of Invasive Cardiology

Clinical Editor's Corner

05/03/2021

Lloyd W. Klein , MD;

Bernhard Meier , MD, FACC, FESC;

Steven L. Goldberg , MD;

Stephen R. Ramee , MD;

Timothy D. Henry , MD;

Paul S. Teirstein , MD, FACC;

Arnold H. Seto , MD, MPA, CCDS, FACC, FSCAI;

Bonnie H. Weiner , MD, MBA, FSCAI, FACC;

Kirk N. Garratt , MD, MSc;